
The Trade Desk (TTD) posted strong Q1 2025 results, with revenue up 25% year-over-year to $616 million and adjusted EBITDA of $208 million significantly surpassing consensus, marking a rebound from a prior quarter miss. This performance was largely attributed to rapid adoption of its Kokai platform and continued leadership in the connected TV (CTV) advertising market. Despite increasing competition, notably from Amazon's DSP, and ongoing macroeconomic caution impacting sectors like CPG and auto, TTD issued Q2 2025 revenue guidance of at least $682 million, indicating sustained growth prospects.
The Trade Desk (TTD) demonstrated a significant operational rebound in its first quarter of 2025, posting revenue of $616 million, a 25% year-over-year increase that surpassed analyst expectations by 7%. This performance, coupled with an adjusted EBITDA of $208 million that beat consensus by 40%, signals a recovery from the previous quarter's guidance miss and suggests internal reorganization challenges have been addressed. Growth is primarily fueled by strong execution in the connected TV (CTV) market and the rapid, ahead-of-schedule adoption of its new Kokai platform by two-thirds of its clients, which has delivered a 24% reduction in cost per conversion. Despite a nearly 39% stock decline over the past six months, the company's fundamentals remain robust, with an 80% gross profit margin and a PEG ratio of 0.85 indicating its premium P/E multiple of 89.5x may be justified by its growth trajectory. However, forward guidance for Q2 2025 projects a more moderate 17% YoY revenue growth to $682 million, reflecting caution around macroeconomic pressures on advertising spend in the consumer packaged goods and automotive sectors. The primary long-term risk remains escalating competition from Amazon's (AMZN) demand-side platform, which poses a threat to market share.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
moderately positive
Sentiment Score
0.65
Ticker Sentiment